Publication Year

Wagner ME, Travis LB. 2008. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 52(3):353–354 (author reply, 355).

Hong B, Garabrant D, Chen Q, Chang C-W, Jiang X, Hedgeman E, Gillespie B, Lepkowski J, Franzblau A. Variable selection methods influence the identification of factors that predict serum dioxin concentrations in Michigan, USA, ISEE-ISEA Joint Annual Conference, Pasadena, CA. October 1. 2008.

Schoonen WM, Cronin-Fenton DP, Riis A, Farkas D, Johnsen SP, Fryzek JP, Sorensen HT. Transfusion use among cancer patients: a population-based cohort study, 33rd ESMO Congress, Stockholm, Sweden. September 12-16 2008.

Thomsen RW, Thomsen HF, Nørgaard M, Cetin K, McLaughlin JK, Tarone RE, Fryzek JP, Sørensen HT. 2008. Risk of cholecystitis in patients with cancer: A population-based cohort study in Denmark. Cancer 113(12):3410-3419.

Jensen AO, Nørgaard M, Cronin-Fenton D, Rubino A, Fryzek JP, Sørensen HT. Accuracy of ICD-10 discharge diagnoses of skeletal related events (SREs) and bone metastases secondary to prostate cancer and breast cancer in a Danish population-based hospital registry 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Copenhagen, Denmark. August 17-20, 2008.

Sekeres MA, Schoonen WM, Kantarjian H, List A, Fryzek J, Paquette R, Maciejewski JP. 2008. Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys. J Natl Cancer Inst 100(21):1542-1551.

Jolliet O, Wenger Y, Adriaens P, Chang C-W, Chen Q, Franzblau A, Gillespie BW, Hedgeman E, Hong B, Jiang X, Knutson K, Lepkowski J, Milbrath MO, Reichert H, Towey T, Garabrant D. Explaining age dependency using pharmacokinetic modeling in the analysis of blood TCDD concentrations. Dioxin 2008 Conference, Birmingham, England. August 1, 2008.

Garabrant DH, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie BW. Factors that predict serum PCB concentrations in Michigan, USA. Dioxin 2008 Conference, Birmingham, England. August 1, 2008.

Knutson K, Hong B, Jiang X, Hedgeman E, Chen Q, Chang C-W, Towey T, Gillespie BW, Franzblau A, Lepkowski J, Adriaens P, Demond A, Garabrant DH. The relationship between dioxin concentrations in blood and breast feeding. Dioxin 2008 Conference. Birmingham, England. August 1, 2008.

Garabrant D, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie BW Predictors of serum PCDF concentrations in people from, Michigan, USA.Dioxin 2008 Conference,Birmingham, England. August 1, 2008.

Gillespie BW, Reichert H, Chang C-W, Hedgeman E, Hong B, Chen Q, Jolliet O, Knutson K, Lee S-Y, Lepkowski J, Olsen K, Adriaens P, Demond A, Towey T, Ward B, Luksemburg W, Maier M, Franzblau A, Garabrant D, and University of Michigan Dioxin Exposure Study Team. “Predictors of 7 dioxin congeners in background US populations: Data from two Michigan counties and the US National Health and Nutrition Examination Survey. Dioxin 2008 Conference, Birmingham, England. August 1, 2008.

Garabrant D, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie BW. 2008. Predictors of serum PCB concentrations in people from Michigan, USA. Organohalogen Compounds 70:1236–1239.

Garabrant D, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie BW. 2008. Predictors of serum TEQ and PCDD concentrations in people from Michigan, USA. Organohalogen Compounds 70:94–97.

Garabrant D, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie BW. 2008. Predictors of serum PCDF concentrations in people from Michigan, USA. Organohalogen Compounds 70:2047–2050.

Jolliet O, Jiang X, Wenger Y, Milbrath MO, Chang C-W, Chen Q, Hong B, Hedgeman E, Garabrant D, Franzblau A, Lepkowski J, Towey T, Adriaens P, Gillespie BW. 2008. Model formats and use of pharmacokinetic modeling for the statistical analysis of blood dioxin concentrations. Organohalogen Compounds 70:102–105.

Jolliet O, Wenger Y, Adriaens P, Chang C-W, Chen Q, Franzblau A, Gillespie BW, Hedgeman E, Hong B, Jiang X, Knutson K, Lepkowski J, Milbrath MO, Reichert H, Garabrant D. 2008. Influence of age on serum dioxin concentrations as a function of congener half-life and historical peak environmental contamination. Organohalogen Compounds 70:1936–1938.

Knutson K, Hong B, Chen Q, Chang C-W, Jiang X, Hedgeman E, Towey T, Gillespie BW, Franzblau A, Lepkowski J, Adriaens P, Demond A, Garabrant DH. 2008. The relationship between dioxin concentrations (TEQ) in blood and breast feeding. Organohalogen Compounds 70:1387–1390.

Garabrant DH, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, and Gillespie BW. 2008. Factors that predict serum PCB, PCDD, and PCDF concentrations in Michigan, USA. Epidemiology 19(6):S265.

Gillespie BW, Reichert H, Chang C-W, Hedgeman E, Hong B, Chen Q, Jolliet O, Knutson K, Lee S-Y, Lepkowski J, Olsen K, Adriaens P, Demond A, Towey T, Ward B, Luksemburg W, Maier M, Franzblau A, Garabrant D, and University of Michigan Dioxin Exposure Study Team. Predictors of 8 furan congeners in background US populations: Data from two Michigan counties and the US National Health and Nutrition Examination Survey. Dioxin 2008 Conference, Birmingham, England. August 1, 2008.

Olsen JH, Friis S, Poulsen AH, Fryzek J, Harving H, Tjønneland A, Sørensen HT, Blot W. 2008. Use of NSAIDs, smoking and lung cancer risk. Br J Cancer 98(1):232-237.

Jolliet O, Wenger Y, Adriaens P, Chang C-W, Chen Q, Franzblau A, Gillespie BW, Hedgeman E, Hong B, Jiang, X, Knutson K, Lepkowski J, Milbrath MO, Reichert H, Towey T and Garabrant D. Influence of age on dioxin serum concentrations as a function of congener half-life and historical peak food consumption Dioxin 2008 Conference, Birmingham, England. August 1, 2008.

Schoonen W, Thomsen RW, Körmendiné Farkas D, Riis A, Fryzek JP, Sorensen HT. Incidence of infections in splenectomised patients and general population comparisons: nationwide cohort study in Denmark 13th Congress of the European Heamatology Association, Copenhagen, Denmark. June 12-15, 2008.

Schoonen W, Thomsen RW, Körmendiné Farkas D, Riis A, Fryzek JP, Sorensen HT.Splenectomy for trauma or Immune Thrombocytopenic Purpura (ITP) and risk of infections, venous thromboembolic events and death. 13th Congress of the European Heamatology Association, Copenhagen, Denmark. June 12-15, 2008.

Carducci MA, Cetin K, Markus R, Fryzek JP. Time trends in the epidemiology of newly diagnosed stage IV prostate cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program (1988-2003). American Society of Clinical Oncology Annual Conference, Chicago, IL. May 30 – June 3, 2008.

Cetin K, Cronin-Fenton DP, Søndergaard F, Pedersen L, Fryzek JP, Acquavella JF, Baron JA, Sørensen HT Risk of venous thromboembolism (VTE) in Danish cancer patients: a population-based cohort study from 1997 to 2005. American Society of Clinical Oncology Annual Conference, Chicago, IL. May 30 – June 3, 2008.

Fryzek JP, Thomsen RW, Thomsen HF, Nørgaard TM, Cetin K, McLaughlin JK, Tarone RE, Sørensen HT The risk of cholecystitis in patients with cancer and the general population in a population-based cohort study in Western Denmark, 1995-2003. American Society of Clinical Oncology Annual Conference, Chicago, IL. May 30 – June 3, 2008.

Bailey WH, Wagner ME. 2008. IARC evaluation of ELF magnetic fields: Public understanding of the 0.4-lT exposure metric. J Exposure Sci Environ Epidemiol 18:233–235.